Go Deep
VolitionRx Limited
VolitionRx Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -16,388 | -0.1 | -0.18 | -0.34 | 17.85 |
| Oct 2026 | -16,380 | -0.0 | -0.17 | -0.34 | 17.06 |
| Oct 2026 | -18,174 | -0.0 | -0.16 | -0.34 | 16.48 |
| Oct 2026 | -18,173 | -0.0 | -0.16 | -0.34 | 16.42 |
| Oct 2026 | -18,166 | -0.0 | -0.16 | -0.34 | 15.74 |
| Oct 2026 | -18,169 | -0.0 | -0.16 | -0.34 | 15.96 |
VolitionRx Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 398,657.0 | 985,076.0 | 447,034.0 | 627,277.0 |
| Net Profit | -7,326,047.0 | -6,664,774.0 | -6,270,832.0 | -5,378,358.0 |
| EPS | -0.8 | -1.0 | — | -1.0 |
VolitionRx Limited Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 1,727,384.0 | 1,233,511.0 | 775,302.0 | 306,392.0 | — |
| Net Profit | -23,357,027.0 | -26,967,836.0 | -35,319,078.0 | -30,268,793.0 | — |
| EPS | -4.4 | -6.2 | -10.0 | -11.0 | — |
VolitionRx Limited Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Total Assets | 6,901,227.0 | 9,399,523.0 | 27,950,498.0 | 18,295,054.0 |
| Total Liabilities | 42,494,038.0 | 35,507,259.0 | 36,662,720.0 | 21,422,016.0 |
| Total Equity | -34,246,393.0 | -24,907,620.0 | -7,802,255.0 | -2,574,991.0 |
Owes vs Owns
VolitionRx Limited owed $5.04 for every $1 it owned in Jun 2026, up from $1.17 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 5.04× | 6.16× | 3.78× | 1.31× | 1.17× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
VolitionRx Limited Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 16.2%Receivables 4.6%Fixed assets (tangible) 65.5%Intangible assets 4.6%Other assets 9.1%
How it's funded — Dec 2025
Short-term debt 7.8%Long-term debt 17.1%Payables 6.9%Other liabilities 68.3%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1.1 | 3.3 | 20.7 | 10.9 |
| Receivables | 0.3 | 0.1 | 0.2 | 0.1 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 4.5 | 5.0 | 6.1 | 6.0 |
| Intangible assets | 0.3 | 0.3 | 0.0 | 0.1 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.6 | 0.7 | 0.9 | 1.2 |
| Liabilities & equity | ||||
| Short-term debt | 3.3 | 0.9 | 1.2 | 1.1 |
| Long-term debt | 7.3 | 4.0 | 3.6 | 2.8 |
| Payables | 2.9 | 2.8 | 3.2 | 3.0 |
| Other liabilities | 29.0 | 27.9 | 28.6 | 14.5 |
| Shareholders' equity | -35.6 | -26.1 | -8.7 | -3.1 |
| Net tangible assets | -34.6 | -25.2 | -7.8 | -2.7 |
VolitionRx Limited Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -19,683,334.0 | -25,893,624.0 | -18,062,999.0 | -15,277,742.0 | — |
| Investing Activities | -89,558.0 | -573,852.0 | -1,083,749.0 | -1,570,182.0 | — |
| Financing Activities | 17,092,858.0 | 8,657,254.0 | 28,982,685.0 | 6,938,032.0 | — |